SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-14-000811
Filing Date
2014-12-19
Accepted
2014-12-19 10:57:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR BIOSPECIFICS TECHNOLOGIES BY ABDIEL QUALIFIED MASTER FUND LP s13g_121814-biospfstechcorp.htm SC 13G 123637
  Complete submission text file 0000904454-14-000811.txt   125078
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79091 | Film No.: 141297927
SIC: 2834 Pharmaceutical Preparations

Mailing Address 89 NEXUS WAY CAMANA BAY E9 KY1-9007
Business Address 410 PARK AVENUE SUITE 530 NEW YORK NY 10022 646-496-9351
Abdiel Qualified Master Fund LP (Filed by) CIK: 0001508239 (see all company filings)

IRS No.: 208096029 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G